Emmanuelle Trombe represents pharmaceutical, medical device and bio-pharmaceutical companies globally in transactional matters in relation to M&A and divestitures, joint ventures and strategic partnerings, large-scale projects, outsourcing projects, product development, licensing agreements and regulatory matters. She also advises venture capital funds and bio-pharmaceutical companies in connection with a broad range of financing activities.
Emmanuelle Trombe is distinguished in Chambers Europe and Legal 500 EMEA in life sciences transactions, where she is recommended for her expertise in the pharmaceutical, health care, biotech and medical devices industries and described as very responsive, smart, flexible and business-minded.
Socio | Paris
Paris: +33 1 81 69 15 35
Paris: +33 1 81 69 15 15
Shanghai, China / McDermott Event / November 12, 2019
Podcasts / May 22 , 2019
Paris, France / Speaking Engagements / May 16, 2019
San Francisco, California / McDermott Event / January 7-9, 2019
Shanghai, China / McDermott Event / December 5, 2018
London, United Kingdom / McDermott Event / October 4, 2018
Paris, France / McDermott Event / September 25, 2018
Cambridge, Massachusetts / McDermott Event / September 12, 2018
Paris, France / McDermott Event / July 10, 2018
Boston, Massachusetts / McDermott Event / June 6, 2018
Boston, Massachusetts / Speaking Engagements / June 3, 2018
Shanghai, China / McDermott Event / November 16, 2017
Paris, France / McDermott Event / May 23, 2017
Tokyo, Japan / McDermott Event / January 25 - 26, 2017
San Francisco, California / McDermott Event / January 10, 2017
International News / Fall 2016
Pubblicazioni / February 23, 2015
A Legal Guide to Investing in France for Foreign Investors
Biotech Finances / February 6, 2015
Open Innovation Pharma: Legal instructions (French version)
International News / Winter 2014
1
2
3
4
Global Legal Chronicle / October 21, 2019
Paris / Press Releases / October 17, 2019
McDermott advises DBV Technologies on its $143 million capital increase
Paris / Press Releases / October 16, 2019
McDermott advises Sensorion in connection with its EUR 18.1million capital increase
London / Press Releases / September 18, 2019
McDermott to Host European Healthcare Private Equity Leadership Forum 2019
Paris / Press Releases / April 16, 2019
McDermott Advises DBV Technologies In Connection With Its $81 Million Capital Increase
London / Accolades & Rankings / April 15, 2019
Paris / Press Releases / March 25, 2019
McDermott Advised Vivet Therapeutics on the Sale of its Equity to Pfizer
Paris / Press Releases / March 25, 2019
McDermott advises PDC*line in license agreement with LG Chem for lung ...
London / Accolades & Rankings / March 18, 2019
Law 360 / November 20, 2018
Press Releases / October 26, 2018
McDermott Advises Innate Pharma in Expanding its Collaboration with AstraZeneca
Paris / Press Releases / October 18, 2018
McDermott Advises the Shareholders of H-Immune in the Sale of their Shares ...
Le Monde du Droit (France) / September 6, 2018
Paris / Global Legal Chronicle / December 27, 2017
Paris / Global Legal Chronicle / December 27, 2017
Sensorium Signs Collaboration Agreement with Cochlear Limited
Paris / Le Monde du Droit / December 26, 2017
Paris / Le Monde du Droit / December 26, 2017
Paris / Press Releases / December 20, 2017
McDermott advises Sensorion on its collaboration with Cochlear
Paris / Le Monde du Droit / December 14, 2017
Paris / Capital Finance / November 20, 2017
Scipio Bioscience Completes a € 1.2m Seed Round by Turning to Seventure and ...
Paris / Global Legal Chronicle / November 20, 2017
Paris / Le Monde du Droit / November 17, 2017
Fiducial Legal by Lamy Advises the Quadrivium Priming Fund 1
Paris / Magazine des Affaires / November 9, 2017
Private Equity: Health “In Vogue” | 2017 Guide to Intermediate Businesses
Paris / Global Legal Chronicle / November 2, 2017
Paris / Le Monde du Droit / November 1, 2017
Paris / Press Releases / October 30, 2017
McDermott Advised Poxel on Its Strategic Partnership with Sumitomo Dainippon Pharma for ...
Paris / Legal Monitor / October 6, 2017
Harmony Biosciences acquires US rights to Pitolisant from Bioprojet
Paris / Press Releases / October 6, 2017
Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet
Bruxelles / Press Releases / June 30, 2017
Paris / Legal Monitor / June 8, 2017
McDermott Will & Emery Represents Innate Pharma in Acquisition of Anti-C5aR
Paris / Le Monde du Droit / June 8, 2017
McDermott Will & Emery and Baker McKenzie on Innate Pharma Acquisition
Paris / Press Releases / June 6, 2017
McDermott Will & Emery Represents Innate Pharma in Acquisition of Anti-C5aR
Düsseldorf / Accolades & Rankings / April 18, 2017
McDermott Recommended in Legal 500 EMEA 2017 and Top-Tier Ranked in France for Healthcare ...
Düsseldorf / Accolades & Rankings / April 10, 2017
Paris / Décideurs Magazine Guide 2017 (France) / April 2017
Leading Lawyers in Life Sciences – McDermott: A Global Expertise
Paris / Le Monde du Droit (France) / March 17, 2017
Paris / Legal Monitor / March 17, 2017
McDermott Advised Servier on its Partnership with Neurochlore
Paris / Accolades & Rankings / March 17, 2017
McDermott Scoops Highest Accolades by the Trophées du Droit, Décideurs 100 ...
Paris / Le Monde du Droit (France) / March 16, 2017
Paris / Press Releases / March 15, 2017
McDermott Advised Servier on its Partnership with Neurochlore
Paris / Legal Monitor (UK) / January 10, 2017
McDermott Advised Servier in its License Option Agreement with OSE Immunotherapeutics
Paris / Press Releases / January 9, 2017
Le Monde du Droit (France) / January 6, 2017
Paris / Press Releases / January 6, 2017
McDermott Will & Emery Advised Servier in its License Option Agreement with OSE ...
Magazine des Affaires (France) / December 2016
Le Monde du Droit (France) / November 23, 2016
Paris / Press Releases / November 23, 2016
McDermott Will & Emery Advises Acticor Biotech on its Partnership with Mediolanum Farmaceutici
Paris / Press Releases / November 21, 2016
McDermott Will & Emery Advises BIOCORP on its Partnership with Aguettant
Paris / Press Releases / November 8, 2016
McDermott Will & Emery advised Dynacure on its partnership with SATT Conectus and ...
London / In-Pharma Technologist / July 27, 2016
GSK Commits to UK Manufacturing with £275m Investments Across Three Sites
Legal Monitor / July 26, 2016
CF News (France) / July 21, 2016
Le Monde du Droit (France) / July 20, 2016
Chammas Marcheteau Advises Quattrocento and Its Shareholders
Capital Finance (France) / July 18, 2016
London / Drug Discovery News / July 2016
Paris / Press Releases / June 13, 2016
McDermott Advises Inventiva on its Research Project with Boehringer Ingelheim
Paris / Press Releases / June 9, 2016
McDermott Advises DBV Technologies on its Global Collaboration with Nestlé Health Science
La Lettre des Juristes d’Affaires (France) / June 6, 2016
McDermott and Linklaters on the Collaboration of Nestle and DBV Technologies
Paris / Le Monde du Droit (France) / June 2, 2016
Capital Finance / January 18, 2016
La Lettre des Juristes d’Affaires (France) / January 18, 2016
McDermott and Jones Day Advise on the Licensing Agreement Between Innate Pharma ...
Le Monde du Droit / January 13, 2016
Décideurs Strategie Finance Droit, 2015 Guide (France) / 2015
Paris / Press Releases / December 3, 2015
McDermott Advises Servier on Strategic Agreement with Cellectis
Le Monde du Droit (France) / November 25, 2015
Press Releases / November 19, 2015
McDermott Advises Pierre Fabre on Framework of Collaboration Agreement Entered into with ...
Le Monde du Droit (France) / November 18, 2015
Décideurs Stratégie Finance Droit (France) / November 17, 2015
Pierre Fabre and Array BioPharma Announce Collaboration in Oncology
Law in France / November 17, 2015
McDermott Advises Pierre Fabre on Cooperation Agreement with Array BioPharma
Acquisition International / August 6, 2015
International Law Firm McDermott Will & Emery Advised the Shareholders of Anaconda Pharma ...
La Lettre des Juristes d’Affaires (France) / July 27, 2015
Five Firms Advise on the Capital Increase for DBV Technologies
Press Releases / July 24, 2015
DBV Technologies advised by McDermott Will & Emery on 2015’s Largest NASDAQ Secondary ...
Le Monde du Droit (France) / July 22, 2015
McDermott Will & Emery and D’hoir Beaufre Assist DBV Technologies
Law in France / July 21, 2015
McDermott Will & Emery and D’Hoir Beaufre Represent DBV Technologies
La Lettere des Juristes d’Affaires (France) / June 22, 2015
McDermott and WSGR Advise on the Agreement Between Servier and Taiho for ...
Le Monde du Droit (France) / June 18, 2015
McDermott advises Servier as Part of the Agreement with Taiho Pharmaceutical Co., ...
Le Monde du Droit (France) / June 9, 2015
Law in France / June 8, 2015
Capital Finance (France) / June 1, 2015
Düsseldorf / Accolades & Rankings / May 5, 2015
McDermott European Practice Shows Continuous Growth in Ranking Results in Chambers Europe 2015
Paris / La Lettre des Juristes d’Affaires (France) / May 4, 2015
McDermott and Wragge Advise on the Alliance Between Innate Pharma and Astrazeneca
Paris / Press Releases / April 30, 2015
McDermott Represents Innate Pharma on US1.2 Billion Partnering Agreement with AstraZeneca
London / Le Monde du Droit (France) / April 29, 2015
Paris / Option Droit & Affaires (France) / April 29, 2015
McDermott and Wragge Advised on the Agreement between Innate Pharma and Astrazeneca
Law in France / April 28, 2015
McDermott Will & Emery Advised Innate Pharma on the Framework of a Major ...
Paris / Legal Monitor (UK) / March 17, 2015
McDermott Advises Anaconda Pharma Shareholders on Sale to Biota Pharmaceuticals
Paris / / March 11, 2015
McDermott Advises Anaconda Pharma Shareholders on Sale to Biota Pharmaceuticals
Le Monde du Droit (France) / March 3, 2015
Law360 / February 19, 2015
McDermott Will & Emery Advised Cytune Pharma in Significant Minority Stake Purchase by ...
Law360 / February 2, 2015
Paris / Press Releases / February 2, 2015
McDermott Advises Acticor Biotech on Development of Emergency Treatment for Ischemic Stroke
Le Monde du Droit (France) / December 19, 2014
Le Monde du Droit (France) / December 2, 2014
Servier Strategic Partnership with Intarcia Therapeutics, Inc: Interview with Emmanuelle Trombe
Paris / Press Releases / November 21, 2014
McDermott Advises Servier in its Strategic Partnership with Intarcia Therapeutics Valued at ...
Option Droit & Affaires (France) / November 19, 2014
McDermott Advises on the Partnership Between Servier and Intarcia
Option Droit & Affaires (France) / November 19, 2014
Jones Day and McDermott Advised on the Fundraising by Theranexus
Le Monde du Droit (France) / November 14, 2014
Capital Finance (France) / October 6, 2014
Le Monde du Droit (France) / September 22, 2014
Droit-inc (France) / May 20, 2014
Le Monde du Droit (France) / May 19, 2014
Who's Who Legal / May 14, 2014
McDermott Will & Emery Hires Leading Transactional Lawyer in Paris
The Lawyer (UK) / April 28, 2014
Le Monde du Droit (France) / April 21, 2014
The Lawyer (UK) / April 17, 2014
The AmLaw Daily / April 11, 2014
Bloomberg News / April 10, 2014
Droit-inc (France) / April 10, 2014
La vie après 11 ans dans Dechert (Life After 11 Years at Dechert)
Press Releases / April 9, 2014
McDermott Boosts Life Sciences Practice with Addition of High-Profile Partner in Paris
Le Monde du Droit (France) / April 9, 2014
Emmanuelle Trombe rejoint McDermott (Emmanuelle Trombe Joins McDermott)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
... 19
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
